Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Janssen Research & Development"
Count: 985
Selected: 0
| NCT ID | Title |
|---|
| NCT05896683 | A Study of Lazertinib (JNJ-73841937) Tablet in Healthy Adult Participants | ||
| NCT05498428 | A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer | ||
| NCT05423106 | A Single and Multiple Ascending Dose Study of JNJ-64457744 | ||
| NCT05572515 | A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04844463 | A Study of JNJ-68179280 in Healthy Participants | ||
| NCT05841030 | A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) | ||
| NCT05703841 | A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants | ||
| NCT05663866 | Premedication to Reduce Amivantamab Associated Infusion Related Reactions | ||
| NCT05338775 | A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT04951154 | A Study to Examine Biomarkers From Lung and Blood Samples in Participants With Suspected Lung Cancer | ||
| NCT02406027 | An Extension Study to Evaluate the Long-Term Safety and Tolerability of JNJ-54861911 in Participants in the Early Alzheimer's Disease Spectrum | ||
| NCT05818683 | A Study of JNJ-78278343 in Combination With JNJ-63723283 (Cetrelimab) for Metastatic Castration-Resistant Prostate Cancer | ||
| NCT05742594 | A Study of Four Different Oral Tablet Formulations of Lazertinib (JNJ-73841937) in Healthy Adult Participants | ||
| NCT05541315 | A Single Ascending Dose Study of JNJ-88260237 in Healthy Participants | ||
| NCT05014360 | A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis | ||
| NCT05884398 | A Study of an Intermittent ADT Approach With Apalutamide Monotherapy in Participants With mCSPC | ||
| NCT05884242 | A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge | ||
| NCT03412565 | A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens | ||
| NCT03277105 | A Study of Subcutaneous Versus (vs.) Intravenous Administration of Daratumumab in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT03201965 | A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis | ||
| NCT02076009 | A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma | ||
| NCT01974440 | A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma | ||
| NCT01776840 | A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma | ||
| NCT05827874 | A Study on the Effect of Nipocalimab on Vaccine Responses in Healthy Participants | ||
| NCT05811351 | A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) | ||
| NCT05757869 | A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation | ||
| NCT05754957 | A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome | ||
| NCT05702034 | A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE | ||
| NCT05653427 | A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular Carcinoma | ||
| NCT05652335 | A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05564052 | A Study of Ibrutinib With Rituximab in Relapsed/Refractory Mantle Cell Lymphoma | ||
| NCT05550532 | A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy | ||
| NCT05528510 | A Study of Guselkumab Therapy in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT05518149 | A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) | ||
| NCT05488314 | A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung Cancer | ||
| NCT05455684 | A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy | ||
| NCT05455320 | A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05453903 | A Study of JNJ-75276617 in Combination With Acute Myeloid Leukemia (AML) Directed Therapies | ||
| NCT05444530 | A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative Neoplasms | ||
| NCT05438043 | A Study of Daratumumab | ||
| NCT05424822 | A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) | ||
| NCT05388669 | A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer | ||
| NCT05379634 | A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies | ||
| NCT05379595 | A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer | ||
| NCT05364554 | A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis | ||
| NCT05316155 | Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer | ||
| NCT05265273 | A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis | ||
| NCT05252533 | A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis | ||
| NCT05242484 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT05242471 | A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease |
